期刊文献+

益母草注射液联合缩宫素预防阴道分娩产后出血的临床观察 被引量:9

Clinical observation of Yimucao Injection combined oxytocine for preventing postpartum hemorrhage after vaginal delivery
下载PDF
导出
摘要 目的探讨益母草注射液联合缩宫素注射液预防阴道分娩产后出血和促进子宫复旧的效果。方法将该院经阴道分娩的285例患者随机分为益母草组(A组)、益母草联合缩宫素组(B组)、缩宫素组(C组)。观察产后各时段阴道流血量,子宫复旧情况,产前、产后血红蛋白变化,产后恶露情况,血压、心率的变化以及药物不良反应等。结果 A、B组患者产后阴道流血量、产后子宫复旧、产后恶露时间优于C组,各组产妇产前、产后血红蛋白,血压及心率在用药前后无明显改变。各组均未发生不良反应。结论益母草注射液能够减少产后出血,有缓慢、持续的缩宫效果,与缩宫素注射液联用预防产后出血效果更好,且药物安全性良好。 Objective To investigate the effects of Yimucao Injection combined oxytoeine to prevent postpartum hemorrhage and promote involution of utecus after vaginal delivery. Methods 285 cases of vaginal delivery in our hospital were randomly divided into the Yimucao group (A), Yimucao plus oxytocine group (B) and oxytoeine group (C). The postpartum vaginal bleeding volume in various time intervals,involution of uterus,changes of postpartum hemoglobin,changes of loehia,changes of blood pressure, heart rate and drng adverse reactions were observed in various groups. Results The postpartum vaginal bleeding volume,involution of uterus and lochia time in the group A and B were lower, better and shoter than those in the group C. Among 3 groups, there were no significant changes in hemoglobin, blood pressure and heart rate during prepartum and postpartum periods,and no drug adverse reactions occurred. Conclusion Yimucao Injection can reduce the postpartum vaginal bleeding with slow and persistent uterine contraction effects ,and its use in combination with oxytoeine has better effects for preventing postpartum vaginal bleeding and better safety.
出处 《现代医药卫生》 2012年第17期2577-2578,2580,共3页 Journal of Modern Medicine & Health
关键词 益母草 治疗应用 催产素 治疗应用 注射剂 产后出血 治疗 阴道分娩 Leonurus heterophyttus/therapeutic use Oxytocin/therapeutic use Injectio Postpartum hemorrhage/therapy Vaginal delivery
  • 相关文献

参考文献9

二级参考文献46

  • 1南京市围产期保健协作组.2002年南京市10家医院剖宫产后出血的病因分析[J].现代妇产科进展,2005,14(2):90-92. 被引量:38
  • 2曾蔚越.孕产期出血的诊治流程[J].中华妇幼临床医学杂志(电子版),2006,2(3):179-180. 被引量:12
  • 3徐爱群,曾蔚越,吴大蓉,游泳,刘兴会,邢爱耘,周容.益母草注射液缩宫止血疗效初步观察[J].中华妇幼临床医学杂志(电子版),2007,3(2):88-90. 被引量:104
  • 4蔡平生,许群,方轶萍.卡前列素氨丁三醇治疗难治性产后出血[J].温州医学院学报,2007,37(2):188-189. 被引量:11
  • 5乐杰.妇产科学[M].5版.北京:人民卫生出版社,2002:484.
  • 6Aronsson A, Bygderna M, Gemzell - Danielsson K. Effects of misprostol on uterine contractility following different routes of administration [ J ]. Hum Reprod ,2004,19 ( 1 ) : 81 - 84.
  • 7Arias, Femando. Pharmacology of oxytocin and prostaglanding [ J ]. J Clin Ohstet&Gynecol, 2000,43 ( 3 ) : 455 - 468.
  • 8Biancani P. Diversity of Ca(2 + ) -mobilizing mechanisms focus on "eGMP- mediated Ca2 + release from IP3 -insensitive Ca2 + stores in smooth muscle"[ J]. Am J Physiol. 1998,274(5): 1196 - 1198.
  • 9刘铭 段涛.产后出血的预防和处理指南.现代妇产科杂志,2007,:179-180.
  • 10乌毓明,中国计划生育学杂志,1992年,2卷,16页

共引文献1143

同被引文献110

  • 1刘建平,夏芸.中文期刊发表的中医药系统综述或Meta-分析文章的质量评价[J].中国中西医结合杂志,2007,27(4):306-311. 被引量:59
  • 2吴连方,刘妍,阮焱.卡前列素防治高危产妇剖宫产术中及术后出血的临床研究[J].中华妇产科杂志,2007,42(9):577-581. 被引量:106
  • 3王志容,饶建云,肖小玲,王小平,钟燕莉.卡孕栓不同时间给药预防产后出血的临床观察[J].中国药房,2007,18(35):2768-2769. 被引量:16
  • 4Su LL,Chong YS, Samuel M. Carbetocin for preventingpostpartum haemorrhage [J]. Cochrane Database Syst Rev, 2012,2: CD005457.
  • 5中华医学会妇产科学分会产科学组.(草案)[J].中华妇产科杂志,2009, 44(7): 554-557.
  • 6Raj an PV, Wing DA. Postpartum hemorrhage: evidence-basedmedical interventions for preventions and treatment[J]. ClinObstet Gynecol; 2010, 53(1): 165-181.
  • 7Chen Z, Wu JB, Liao X], et al. Development and validation of anUPLC-DAD-MS method for the determination of leonurine inChinese motherwort (Leonurus japonicus)[J]. J ChromatogrSci, 2010, 48(10): 802-806.
  • 8Higgins J, Green S. Cochrane handbook for systematicreview of interventions version 5.1.0 [updated March 2011].The Cochrane Collaboration, 2011. Available from www.cochranehand-book.org.
  • 9Balki M, Ronayne M, Davies S, et al. Minimum oxytocin doserequirement after cesarean delivery for labor arrest[J]. ObstetGynecol, 2006, 107(1): 45-50.
  • 10Bai J, Sun Q, Zhai H. A comparison of oxytocin and carboprnst tromethamine in the prevention of postpartumhemorrhage in high- risk patients undergoing cesarean delivery. Exp Ther Med, 2014, 7(1):46-50.

引证文献9

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部